Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Lund T, Gundesen MT, Juul Vangsted A, Helleberg C, Haukås E, Silkjær T, Asmussen JT, Manuela Teodorescu E, Amdi Jensen B, Schmidt Slørdahl T, Nahi H, Waage A, Abildgaard N, Schjesvold F; Nordic Myeloma Study Group. Lund T, et al. Among authors: schjesvold f. Blood Cancer J. 2024 Apr 15;14(1):65. doi: 10.1038/s41408-024-01046-2. Blood Cancer J. 2024. PMID: 38622134 Free PMC article. No abstract available.
[Investigation of anemia].
Schjesvold F, Wiencke K, Tjønnfjord GE. Schjesvold F, et al. Tidsskr Nor Laegeforen. 2013 Mar 19;133(6):610. doi: 10.4045/tidsskr.13.0256. Tidsskr Nor Laegeforen. 2013. PMID: 23552139 Free article. Norwegian. No abstract available.
Immunologiske mekanismer for drap av kreftceller.
Schjesvold FH. Schjesvold FH. Tidsskr Nor Laegeforen. 2017 Jan 10;137(1):58. doi: 10.4045/tidsskr.16.0963. eCollection 2017 Jan. Tidsskr Nor Laegeforen. 2017. PMID: 28073239 Free article. Norwegian. No abstract available.
[Investigation of amyloidosis].
Schjesvold FH. Schjesvold FH. Tidsskr Nor Laegeforen. 2013 Feb 5;133(3):266. doi: 10.4045/tidsskr.13.0044. Tidsskr Nor Laegeforen. 2013. PMID: 23381155 Free article. Norwegian. No abstract available.
[Erythrocytosis as a problem].
Schjesvold FH. Schjesvold FH. Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2387; author reply 2387. doi: 10.4045/tidsskr.09.1196. Tidsskr Nor Laegeforen. 2009. PMID: 19935946 Free article. Norwegian. No abstract available.
[Monoclonal gammopathy of clinical importance].
Tjønnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK. Tjønnfjord GE, et al. Tidsskr Nor Laegeforen. 2021 Sep 24;141(2021-13). doi: 10.4045/tidsskr.20.0981. Print 2021 Sep 28. Tidsskr Nor Laegeforen. 2021. PMID: 34596996 Free article. Norwegian.
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial.
Dimopoulos MA, Gay F, Schjesvold F, Beksac M, Hajek R, Weisel KC, Goldschmidt H, Maisnar V, Moreau P, Min CK, Pluta A, Chng WJ, Kaiser M, Zweegman S, Mateos MV, Spencer A, Iida S, Morgan G, Suryanarayan K, Teng Z, Skacel T, Palumbo A, Dash AB, Gupta N, Labotka R, Rajkumar SV; TOURMALINE-MM3 study group. Dimopoulos MA, et al. Among authors: schjesvold f. Lancet. 2019 Jan 19;393(10168):253-264. doi: 10.1016/S0140-6736(18)33003-4. Epub 2018 Dec 10. Lancet. 2019. PMID: 30545780 Clinical Trial.
93 results